Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of cells with an abnormal number of chromosomes—known as aneuploid cells—and raised findings that may advance new cancer treatments.
Medical Xpress – latest medical and health news stories
